METHAMPEX Drug Patent Profile
When do Methampex patents expire, and when can generic versions of Methampex launch?
Methampex is a drug marketed by Teva and is included in one NDA.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methampex
A generic version of METHAMPEX was approved as methamphetamine hydrochloride by DR REDDYS LABS SA on April 21st, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHAMPEX?
- What are the global sales for METHAMPEX?
- What is Average Wholesale Price for METHAMPEX?
Summary for METHAMPEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 3,447 |
| DailyMed Link: | METHAMPEX at DailyMed |
US Patents and Regulatory Information for METHAMPEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | METHAMPEX | methamphetamine hydrochloride | TABLET;ORAL | 083889-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
